MLYS · Categories · Coverage

MLYS - Analyst coverage initiated

Mineralys Therapeutics Inc. (MLYS) analyst coverage initiated - real-time wire coverage filtered to Coverage only.

Recent Coverage for MLYS

• 57d
  TD Cowen initiated coverage on Mineralys Therapeutics

  TD Cowen initiated coverage of Mineralys Therapeutics with a rating of Buy
• 377d
  Jefferies initiated coverage on Mineralys Therapeutics with a new price target

  Jefferies initiated coverage of Mineralys Therapeutics with a rating of Hold and set a new price target of $15.00
• 713d
  H.C. Wainwright initiated coverage on Mineralys Therapeutics with a new price target

  H.C. Wainwright initiated coverage of Mineralys Therapeutics with a rating of Buy and set a new price target of $30.00
• 812d
  Goldman initiated coverage on Mineralys Therapeutics with a new price target

  Goldman initiated coverage of Mineralys Therapeutics with a rating of Buy and set a new price target of $30.00
• 1204d
  Evercore ISI initiated coverage on Mineralys Therapeutics

  Evercore ISI initiated coverage of Mineralys Therapeutics with a rating of Outperform
• 1204d
  BofA Securities initiated coverage on Mineralys Therapeutics with a new price target

  BofA Securities initiated coverage of Mineralys Therapeutics with a rating of Buy and set a new price target of $39.00
• 1204d
  Guggenheim initiated coverage on Mineralys Therapeutics with a new price target

  Guggenheim initiated coverage of Mineralys Therapeutics with a rating of Buy and set a new price target of $32.00
• 1204d
  Wells Fargo initiated coverage on Mineralys Therapeutics with a new price target

  Wells Fargo initiated coverage of Mineralys Therapeutics with a rating of Overweight and set a new price target of $27.00
• 1204d
  Stifel initiated coverage on Mineralys Therapeutics with a new price target

  Stifel initiated coverage of Mineralys Therapeutics with a rating of Buy and set a new price target of $45.00
• 1204d
  Credit Suisse initiated coverage on Mineralys Therapeutics with a new price target

  Credit Suisse initiated coverage of Mineralys Therapeutics with a rating of Outperform and set a new price target of $40.00

Other MLYS categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings